Many have been watching as the psychedelic renaissance has taken off and more clinical trials for psychedelic-assisted therapy have begun. Here at Portland Psychotherapy, our research team has been working tirelessly to prepare for our Clinical Trial of MDMA-Assisted Therapy for Social Anxiety Disorder (SAD), recently mentioned in the MAPS Investigator-Initiated Trial update here. Our trial aims to test the efficacy and safety of MDMA-Assisted Therapy for SAD, as well as identify and examine how MDMA-assisted therapy works.
Once screened into the study, participants will be randomized into two groups – one group will proceed immediately into treatment and the other will receive treatment after a delay. Both groups will receive two MDMA-assisted therapy sessions, as well as preparation sessions before and integration sessions after the MDMA-assisted therapy sessions.
Recruitment has begun!
We recently started recruitment and are screening volunteers to see if they are eligible. If you are interested in looking into being a participate or want to let someone else know more about trial, we have an informational page on the website.
To stay in the loop about our trial milestones and updates, you can sign up for our mailing list here.
To learn more about our study, including our team, how to donate, information about the study procedure, or how to participate, please visit our website.
Author: Jason Luoma, Ph.D.
Jason is a psychologist and scientist who studies ways to help people with shame, stigma, and social anxiety, including using psychedelic and MDMA-assisted therapy
